Abstract
WNT proteins drive the development and maintenance of many tissues, including bone. It is less clear which of the many WNT proteins act on bone or where these WNTs act in the skeleton; however, loss-of-function mutations in WNT1 cause bone fragility in children and adults. In this issue of the JCI, Joeng and colleagues demonstrate that bone formation is under the control of WNT1 produced by osteocytes, the cells that reside deep in the bone matrix and form dendritic networks. The implication of WNT1 in the control of bone formation identifies a potential new target for the treatment of low bone mass disorders, such as osteoporosis.
Cite
CITATION STYLE
Rauch, F. (2017, June 30). The brains of the bones: How osteocytes use WNT1 to control bone formation. Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI95386
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.